Entrada Therapeutics Inc (TRDA)
15.17
+0.22
(+1.47%)
USD |
NASDAQ |
May 20, 13:53
Entrada Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
Date | Value |
---|---|
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2023
--
Maximum
Mar 2023
--
Average
--
Median
Mar 2023
Debt to Equity Ratio Benchmarks
Catalyst Pharmaceuticals Inc | 0.00 |
Vertex Pharmaceuticals Inc | 0.00 |
Sarepta Therapeutics Inc | 1.289 |
PTC Therapeutics Inc | -0.3183 |
GlycoMimetics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 510.84M |
Total Liabilities (Quarterly) | 241.48M |
Shareholders Equity (Quarterly) | 269.37M |
Current Ratio | 2.381 |